Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun;29(6):1032-1033.
doi: 10.1038/s41431-020-00763-z. Epub 2020 Dec 1.

Regarding the estimations of people affected by rare diseases

Esther Vicente  1   2 , Laura Pruneda  3 , Eva Ardanaz  4   5
Affiliations
Comment

Regarding the estimations of people affected by rare diseases

Esther Vicente et al. Eur J Hum Genet. 2021 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Comment in

  • Reply to E. Vicente et al.
    Rath A, Lambert DM, Olry A, Rodwell C, Le Cam Y. Rath A, et al. Eur J Hum Genet. 2021 Jun;29(6):1034-1035. doi: 10.1038/s41431-020-00764-y. Epub 2020 Dec 1. Eur J Hum Genet. 2021. PMID: 33262444 Free PMC article. No abstract available.

Comment on

References

    1. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165–73. doi: 10.1038/s41431-019-0508-0. - DOI - PMC - PubMed
    1. Vicente E, Pruneda L, Ardanaz E. Paradoja de la rareza: a propósito del porcentaje de población afectada por enfermedades raras [Paradox of rarity: about the percentage of population affected by rare diseases] Gac Sanit. 2020;34:536–8. doi: 10.1016/j.gaceta.2020.02.012. - DOI - PubMed
    1. Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, et al. Rare disease terminology and definitions - a systematic global review: report of the ISPOR rare disease special interest group. Value Heal. 2015;18:906–14. doi: 10.1016/j.jval.2015.05.008. - DOI - PubMed
    1. Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, et al. How many rare diseases are there? Nat Rev Drug Disco. 2020;19:77–8. doi: 10.1038/d41573-019-00180-y. - DOI - PMC - PubMed
    1. Rare diseases and orphan products: accelerating research and development. Washington, DC: The National Academies Press; 2010. - PubMed